Distinguished in Movement Disorders

Hakan Widner

Lund, M, SE 
Distinguished in Movement Disorders
Lund, M, SE 
OverviewLocationsClinical Research

Overview

Hakan Widner practices in Lund, Sweden. Mr. Widner is rated as a Distinguished expert by MediFind in the treatment of Movement Disorders. His top areas of expertise are Movement Disorders, Parkinson's Disease, Drug Induced Dyskinesia, and Multiple System Atrophy.

His clinical research consists of co-authoring 40 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 36 articles and participated in 2 clinical trials in the study of Movement Disorders.

Gender
Male

Locations

Lund, M 22185, Sweden
Other Locations
M, Sweden
Malmoe, M, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 1-2, Randomised, Double-Blind, Placebo Controlled, Safety and Tolerability Study of Intraputamenal Cerebral Dopamine Neurotrophic Factor (CDNF) Infusions Via an Investigational Drug Delivery System to Patients With Parkinson's Disease
Phase 1-2, Randomised, Double-Blind, Placebo Controlled, Safety and Tolerability Study of Intraputamenal Cerebral Dopamine Neurotrophic Factor (CDNF) Infusions Via an Investigational Drug Delivery System to Patients With Parkinson's Disease
Enrollment Status: Completed
Publish Date: January 13, 2020
Intervention Type: Device, Drug
Study Phase: Phase 1/Phase 2
Follow-up Measurement of Brain Phosphodiesterase 10 A (PDE10A) Enzyme Levels in Huntington´s Disease Gene Expansion Carriers, 18 to 28 Months After Initial Positron Emission Tomography (PET) Measurement in CHDIKI1201/PET-HD-PDE10A (NCT02061722)
Follow-up Measurement of Brain Phosphodiesterase 10 A (PDE10A) Enzyme Levels in Huntington´s Disease Gene Expansion Carriers, 18 to 28 Months After Initial Positron Emission Tomography (PET) Measurement in CHDIKI1201/PET-HD-PDE10A (NCT02061722)
Enrollment Status: Completed
Publish Date: October 10, 2019
Intervention Type: Radiation
Study Phase: Early Phase 1
View 1 Less Clinical Trial

40 Total Publications

Mapping the distribution of neurotransmitters to resting-state functional connectivity in Parkinson's disease.
Mapping the distribution of neurotransmitters to resting-state functional connectivity in Parkinson's disease.
Journal: Brain communications
Published: March 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Widner's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile